Radiofrequency catheter ablations provide an effective control of a variety of supraventricular and ventricular tachycardias in adults. This study was designed to evaluate the efficacy and safety of radiofrequency catheter ablations in infants, children and adolescents. Ninty-three ablations were performed in 84 patients ranging from 5 months to 18 years of age. All but 1 patient were successfully treated (98.8%). Two patients required 1 and 2 additional attempts to achieve success. Tachyarrhythmic episodes recurred in 4 patients within 1–5 months after ablation, which were successfully treated by repeating the intervention. Significant complications occurred in 3 of the ablations (3.2%). Although radiofrequency ablations are very effective and safe in pediatric patients, indications should be restricted in patients younger than 4 years because of a higher risk of possibly life-threatening complications.

Keywords:
Catheter ablation, Radiofrequency, Tachycardia, supraventricular, Tachycardia, ventricular, Tachycardia, atrioventricular reentry, Tachycardia, atrioventricular nodal reentry, Tachycardia, ectopic atrial, Wolff-Parkinson-White syndrome, Infant, Child
1.
Budde T, Breithardt G, Borggrefe M, Podczeck A, Langwasser J: Erste Erfahrungen mit der Hochfrequenzstromablation des AV-Leitungssystems beim Menschen. Z Kardiol 1987;76:204–210.
2.
Borggrefe M, Budde T, Podczeck A: High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 1987;10:576–582.
3.
Kugler JD, Danford DA, Houston K, Felix G: Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 1997;80:1438–1443.
4.
Tanel RE, Walsh EP, Triedman JK, Epstein MR, Bergau DM, Saul JP: Five-year experience with radiofrequency catheter ablation: Implications for management of arrhythmias in pediatric and young adult patients. J Pediatr 1997;131:878–887.
5.
Konstantakos AK, Gilkeson RC, Brozovich FV, Lee JH: Massive pericardial hematoma simulating constrictive pericarditis: A complication of radiofrequency catheter ablation. J Thorac Cardiovasc Surg 1998;115:726–727.
6.
Schaffer MS, Silka MJ, Ross BA, Kugler JD: Inadvertent atrioventricular block during radiofrequency catheter ablation: Results of the Pediatric Radiofrequency Ablation Registry. Pediatric Electrophysiology Society. Circulation 1996;94:3214–3220.
7.
Frias PA, Taylor MB, Kavanaugh-McHugh A, Fish FA: Low incidence of significant valvar insufficiency following retrograde aortic radiofrequency catheter ablation in young patients. J Interv Card Electrophysiol 1999;3:181–185.
8.
Olsson A, Darpo B, Bergfeldt L, Rosenqvist M: Frequency and long-term follow-up of valvar insufficiency caused by retrograde aortic radiofrequency catheter ablation procedures. Heart 1999;81:292–296.
9.
Geise RA, Peters NE, Dunnigan A, Milstein S: Radiation doses during pediatric radiofrequency catheter ablation procedures. Pacing Clin Electrophysiol 1996;19(11, pt 1):1605–1611.
10.
Miga DE, McKellar LF, Denslow S, Wiles HB, Case CL, Gillette PC: Incidence of femoral vein occlusion after catheter ablation in children: Evaluation with magnetic resonance angiography. Pediatr Cardiol 1997;18:204–207.
11.
Reich JD, Auld D, Hulse E, Sullivan K, Campbell R: The Pediatric Radiofrequency Ablation Registry’s experience with Ebstein’s anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol 1998;9:1370–1377.
12.
Cilliers AM, du Plessis JP, Clur SA, Dateling F, Levin SE: Junctional ectopic tachycardia in six paediatric patients. Heart 1997;78:413–415.
13.
Rychik J, Marchlinski FE, Sweeten TL, Berul CI, Bhat AM, Collins-Burke C, Vetter VL: Transcatheter radiofrequency ablation for congenital junctional ectopic tachycardia in infancy. Pediatr Cardiol 1997;18:447–450.
14.
Berul CI, Hill SL, Wang PJ, Marx GR, Fulton DR, Estes NA 3rd: Neontal radiofrequency catheter ablation of junctional tachycardias. J Interv Card Electrophysiol 1998;2:91–100.
15.
Kugler JD: Catheter ablation in pediatric patients; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedsise, ed 2. Philadelphia, Saunders, 1995, pp 1524–1536.
16.
Van Hare GF: Indications for radiofrequency ablation in the pediatric population. J Cardiovasc Electrophysiol 1997;8:952–962.
17.
Lindinger A, Heisel A, von Bernuth G, Paul T, Ulmer H, Kienast W, Pitschner H, Kuck K, Hoffmann W: Permanent junctional re-entry tachycardia: A multicentre long-term follow-up study in infants, children and young adults. Eur Heart J 1998;19:936–942.
18.
Tracy CM: Catheter ablation for patients with atrial tachycardia. Cardiol Clin 1997;15:607–621.
19.
Cosio FG, Lopez-Gil M, Goicolea A, Arribas F, Barroso JL: Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol 1993;15;71:705–709.
20.
Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI, Margolis PD, Calame JD, Overholt ED, Lazzara R: Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991;324:1605–1611.
21.
Kay GN, Epstein AE, Dailey SM, Plumb VJ: Role of radiofrequency ablation in the management of supraventricular arrhythmias: Experience in 760 consecutive patients. J Cardiovasc Electrophysiol 1993;4:371–389.
22.
Kalbfleisch SJ, Morady F: Catheter ablation of atrioventricular nodal reentrant tachycardia; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside, ed 2. Philadelphia, Saunders, 1995, pp 1477–1487.
23.
Klein LS, Miles WM, Mitrani RD, Rardon DP, Zipes DP: Ablation of ventricular tachycardia in patients with structurally normal heart; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside, ed 2. Philadelphia, Saunders, 1995, pp 1518–1523.
24.
Cheema AN, Grais IM, Burke JH, Inbar S, Kadish AH, Goldberger JJ: Late recurrence of atrial flutter following radiofrequency catheter ablation. Pacing Clin Electrophysiol 1997;20(12, pt 1):2998–3001.
25.
Mandawat MK, Turitto G, el-Sherif N: Catheter entrapment in the mitral valve apparatus requiring surgical removal: An unusual complication of radiofrequency ablation. Pacing Clin Electrophysiol 1998;21(4, pt 1):772–773.
26.
Benito F, Sanchez C: Radiofrequency catheter ablation of accessory pathways in infants. Heart 1997;78:160–162.
27.
Saul JP, Hulse JE, Papagiannis J, Van Praagh R, Walsh EP: Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation 1994;90:492–499.
28.
Giardina AC, Ehlers KH, Engle MA: Wolff-Parkinson-White syndrome in infants and children: A long-term follow-up study. Br Heart J 1972;34:839–846.
29.
Deal BJ, Keane JF, Gillette PC, Garson A Jr: Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: Management and follow-up. J Am Coll Cardiol 1985;5:130–135.
30.
Naheed ZJ, Strasburger JF, Benson DW Jr, Deal BJ: Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol 1995;75:405–407.
31.
Hindricks G: The Multicenter European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993;14:1644–1653.
32.
Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SK, Liem LB, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E: Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999;99:262–270.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.